Back to all projects Human Digital Twins
Unlocking Healthcare with "Human Digital Twins"
Our Eye includes the most common eye diseases:
- Refractive errors, such as nearsightedness, farsightedness, and astigmatism
- Cataracts
- Glaucoma
- Age-related macular degeneration
- Diabetes-related conditions: diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma
- Dry eye syndrome
The ViciData Eye Digital Twin project is creating an advanced software solution that harnesses the full potential of Artificial Intelligence (AI)
Background
In the world of healthcare, a "digital twin" is a software program that begins with essential patient data, including factors like sex, age, ethnicity, height, body weight, blood pressure, smoking habits, prescription medications, pre-existing medical conditions, family medical history, and occupation.
A "human digital twin" represents a groundbreaking advancement in healthcare technology. It is a software replica of an individual patient, meticulously crafted to aid healthcare professionals in predicting how diseases might impact that specific patient. This invaluable tool guides healthcare providers in making well-informed decisions regarding the most suitable treatment or prevention strategies.
Human digital twins leverage the integration of established human physiology and immunology principles with an individual patient's real-time clinical data. This dynamic approach empowers healthcare teams to generate real-time predictions, offering insights into the course of an ailment as it unfolds.
Beyond infectious diseases, digital twins also find relevance in the realm of personalized medicine, cancer research, preclinical development, and clinical trials. This versatile technology is poised to revolutionize healthcare by improving patient outcomes, increasing operational efficiency, and facilitating the delivery of personalized treatment and high-quality care.
Welcome to a healthcare landscape transformed by "Human Digital Twins," where patient-centric precision and innovation converge to redefine the industry's future.